10-Q: Edgewell Personal Care Reports Q3 Results, Divestiture Impact

Edgewell Personal Care's Q3 fiscal 2026 results show modest net sales growth and stable adjusted EPS, alongside the completion of its Feminine Care segment divestiture.

Summary

• Edgewell Personal Care reported Q3 fiscal 2026 net sales of $570.1 million, a 1.7% increase year-over-year, with organic net sales up 1.1%.
• Net earnings from continuing operations were $12.3 million, or $0.26 per diluted share, compared to $21.5 million, or $0.46 per diluted share, in the prior year.
• Adjusted net earnings from continuing operations were $33.5 million, or $0.72 per diluted share, largely in line with the prior year's $33.6 million, or $0.72 per diluted share.
• The company completed the divestiture of its Feminine Care segment on February 2, 2026, for approximately $340 million.
• Restructuring and related charges totaled $12.7 million for the quarter, with an expected total of $92 million for fiscal 2026.
• Cash flow from operating activities was $47.1 million for the nine months ended June 30, 2026.
• The company had $397.1 million in cash and cash equivalents as of June 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed to slightly positive quarter, with stable adjusted earnings per share despite revenue growth and a significant divestiture impacting reported figures.

Positives

• Net sales increased by 1.7% to $570.1 million in Q3 fiscal 2026.
• Organic net sales grew by 1.1%, indicating underlying business strength.
• North America organic sales increased by 3.0%, driven by volume growth in Sun, Skin Care, and Grooming.
• Adjusted diluted EPS remained stable at $0.72 for Q3 fiscal 2026, matching the prior year's performance.
• The company received approximately $340 million in proceeds from the divestiture of its Feminine Care segment.
• Cash flow from operating activities for the nine months ended June 30, 2026, was $47.1 million.
• The company has $397.1 million in cash and cash equivalents as of June 30, 2026, providing strong liquidity.

Negatives

• Reported net earnings from continuing operations decreased to $12.3 million from $21.5 million in the prior year quarter.
• Reported diluted EPS from continuing operations decreased to $0.26 from $0.46 in the prior year quarter.
• Gross margin decreased by 210 basis points to 42.5% in Q3 fiscal 2026, impacted by core inflation and net tariffs.
• Selling, general, and administrative (SG&A) expenses increased to 19.0% of net sales from 18.0% in the prior year quarter.
• Wet Shave segment profit decreased by 20.9% to $34.9 million, with organic segment profit down 24.7%.
• Sun and Skin Care segment profit, while slightly up on a reported basis, decreased by 1.6% organically.
• Restructuring and related charges amounted to $12.7 million for the quarter, with significant ongoing charges expected.

Risks

• Changes in production costs, including raw material prices and tariffs, could erode profit margins.
• Pricing and availability of raw materials, energy, shipping, and labor can be volatile due to economic conditions and geopolitical developments.
• The conflict in the Middle East has increased energy and transportation costs and caused global supply chain disruptions.
• The company may not be able to offset future cost increases or sustain price increases without impacting volume and market share.
• Risks associated with international operations, including currency fluctuations and geopolitical instability.
• Potential for impairment of goodwill and other intangible assets.
• Disruptions of business due to factors outside of control, such as natural disasters, conflicts, or disease outbreaks.
• Ability to manage evolving global financial risks, including tariffs and foreign currency fluctuations.

Future Outlook

The company expects to incur approximately $92 million in pre-tax restructuring and related charges in fiscal 2026. The company believes its cash on hand, remaining proceeds from the Feminine Care divestiture, cash flows from operations, and borrowing capacity will be sufficient to meet its working capital, interest, R&D, and capital expenditure needs for at least the next 12 months.

Management Comments

• The divestiture of the Feminine Care segment is a key step to transform Edgewell into a more focused, agile and consumer-driven personal care company.
• Net sales in the third quarter of fiscal 2026 increased 1.7%, reflecting a return to growth in North America, partially offset by lower sales in international markets.
• Adjusted net earnings from continuing operations for the third quarter of fiscal 2026 were largely in line with the prior year quarter, primarily due to lower gross margin and higher operating expenses.
• Organic net sales for the first nine months of fiscal 2026 decreased 0.6%, driven by lower volumes in Wet Shave and Skin Care in North America and lower volumes in Sun Care internationally.
• Adjusted net earnings from continuing operations for the first nine months of fiscal 2026 decreased primarily due to lower gross profit and higher operating expenses, partially offset by higher sales and lower interest expense.

Industry Context

StockSavvy.ai notes that Edgewell's performance, particularly the stable adjusted EPS despite revenue growth and the strategic divestiture, aligns with broader industry trends of portfolio optimization and focus on core competencies. The challenges in gross margin due to inflation and tariffs are also common across the consumer staples sector.

Comparison to Industry Standards

• Edgewell's Q3 organic net sales growth of 1.1% is modest compared to some faster-growing consumer staples companies, but stable adjusted EPS suggests effective cost management.
• The gross margin decline due to inflation and tariffs is a widespread issue affecting many companies in the consumer goods sector, including competitors like Procter & Gamble and Kimberly-Clark.
• The divestiture of a non-core segment (Feminine Care) to focus on core brands (Wet Shave, Sun & Skin Care) is a strategic move seen across the industry, aiming for greater agility and profitability.
• The company's investment in advertising and sales promotion (A&P) as a percentage of net sales (14.6% in Q3) is within the typical range for the personal care industry, aiming to support brand strength.

Legal Proceedings

• The company is subject to various legal proceedings in different jurisdictions arising from its operations.
• A $4.7 million charge was recorded in the nine months ended June 30, 2026, related to an offer to settle claims and disputes from a former contract manufacturing agreement.
• The company believes its liability from pending legal proceedings is not reasonably likely to be material to its financial position, results of operations, or cash flows, considering established accruals.

Related Party Transactions

• The company entered into a Transition Services Agreement (TSA) with Essity following the Feminine Care divestiture, providing certain services for an initial duration of twelve months.
• Remuneration for TSA services is intended to recover a significant portion of Edgewell's costs and expenses.
• TSA income recognized was $7.7 million for Q3 2026 and $14.4 million for the nine months ended June 30, 2026.
• As of June 30, 2026, a net payable position of $14.3 million related to the TSA is included in other current liabilities.

Stakeholder Impact

• Shareholders: Stable adjusted EPS provides some reassurance, but reported earnings decline and ongoing restructuring costs may temper sentiment. The divestiture aims to create a more focused company, potentially leading to better long-term shareholder value.
• Employees: Restructuring charges imply potential workforce adjustments, though specific impacts are not detailed.
• Suppliers: Supply chain disruptions and consolidation efforts could impact supplier relationships and terms.
• Creditors: The company's liquidity and debt levels appear manageable, with sufficient cash and borrowing capacity to meet obligations.

Next Steps

• Continue to invest in core brands, capital expenditures, and other growth initiatives with proceeds from the Feminine Care divestiture.
• Complete the consolidation of Mexico facilities by the fourth quarter of fiscal 2026.
• Complete the consolidation of Wet Shave operations in the first half of fiscal 2028.
• Continue to monitor and manage global financial risks, including tariffs and currency fluctuations.
• Evaluate new information regarding potential refunds of IEEPA tariffs and recognize them when ASC 450, Contingencies, requirements are met.

Key Dates

Recommendation

The company demonstrates resilience with stable adjusted EPS and modest sales growth, supported by a strategic divestiture. However, ongoing restructuring costs, margin pressures from inflation and tariffs, and mixed segment performance warrant a cautious approach. The company is navigating a complex environment, and while it is taking steps to improve efficiency and focus, significant headwinds remain. A 'hold' recommendation reflects the balance between these positive and negative factors, suggesting investors await clearer signs of sustained organic growth and margin improvement before considering a buy.

Keywords

Edgewell Personal Care, Form 10-Q, Quarterly Report, Wet Shave, Sun and Skin Care, Feminine Care Divestiture, Financial Results, Restructuring Charges